Search results for: 'rapid molecular diagnostics ad peptid synthesis platforms'

The aim of this research service is to analyse the diabetes diagnostics market in Europe and provide strategic recommendations and conclusions for the success of its participants. The main objective of this research service is to establish an understanding of the key diabetes diagnostics market segments (laboratory-based HbA1C diagnostics, SMBG and...

The diabetes diagnostics market in China is classified into two market segments as laboratory diabetes diagnostics segment and POCT diabetes diagnostics segment. The analysis time frame for this study was from 2005 to 2012{CAGR period}, with 2005 being the base year of the study. The forecast period is 2006 to 2012 and historic period is 2002 to 20...

The diabetes diagnostics market in South Korea is classified into two market segments as laboratory diabetes diagnostics segment and POCT diabetes diagnostics segment. The analysis time frame for this study was from 2002 to 2012, with 2005 being the base year of the study. The forecast period is 2006 to 2012 and historic period is 2002 to 2004.

This research service analyzes the market for diabetes in vitro diagnostics within the United States. This service covers market trends, technology trends, competitive structure, revenue forecasts, market drivers and restraints. The key challenges and strategies are also covered.

01 Jul 2015  |  North America  |  Market Research

Analysis of the US and European Diabetes Diagnostics Market

Constricting Reimbursement Policies Restrain Market Growth

Infographics

×

The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...